Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature-Reference-Cited by-同舟云学术

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

Published:2009-12-24 Issue:1 Volume:120 Page:119-126
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kirova Youlia M.,Savignoni Alexia,Sigal-Zafrani Brigitte,de La Rochefordiere Anne,Salmon Rémy J.,This Pascale,Asselain Bernard,Stoppa-Lyonnet Dominique,Fourquet Alain

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-009-0685-6.pdf

Reference57 articles.

1. Robson ME (2002) Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Cancer Control 9:457–465

2. Adem C, Reynolds C, Soderberg CL et al (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97:1–11

3. Chappuis PO, Nethercot V, Foules WD et al (2000) Clinico-pathological characteristics of BRCA1 and BRCA2-related breast cancer. Semin Surg Oncol 18:287–295

4. Stoppa-Lyonnet D, Ansquer Y, Dreyfus H et al (2000) Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 18:4053–4059

5. Foulkes WD, Chappuis PO, Wong N et al (2000) Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. Ann Oncol 11:307–313

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection;JAMA Surgery;2023-12-01

2. Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer;Journal of Clinical Oncology;2023-02-10

3. A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer;Radiotherapy and Oncology;2022-11

4. Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers;Current Opinion in Oncology;2022-09-27

5. Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting;Critical Reviews in Oncology/Hematology;2022-09